Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 5

Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis

Total article views   Abstract views HTML views PDF downloads Totals
3,721 Dovepress* 3,721 0+ 1,516 3,721
Totals 3,721 0 1,516 3,721
*Since 15 November 2007
+Since July 2016

View citations on Google Scholar